Clinical trial

JP-1730 to Treat Parkinson's Disease

NCT00040209

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-06-01

PhasePHASE2

Study timeline

Study start (unknown)2002-06-01Date precision: month

Registry last updated2008-03-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

JP 1730DRUG

IV LevodopaDRUG

IV ApomorphineDRUG

Sponsors & collaborators

National Institute of Neurological Disorders and Stroke (NINDS)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00040209 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.